Literature DB >> 32754832

Diagnosis of depression in multiple sclerosis is predicted by frontal-parietal white matter tract disruption.

Kira Ashton1,2,3, Tom A Fuchs1,2, Devon Oship1,2, Robert Zivadinov1,4, Dejan Jakimovski1, Niels Bergsland1,5, Deepa P Ramasamy1, Caila Vaughn2, Bianca Weinstock-Guttman1,2, Ralph H B Benedict2, Michael G Dwyer6,7.   

Abstract

BACKGROUND: Persons with multiple sclerosis (PwMS) are at an elevated risk of depression. Decreased Conscientiousness may affect patient outcomes in PwMS. Low Conscientiousness has a strong correlation with depression. Previous work has also reported that white matter (WM) tract disruption in frontal-parietal networks explains reduced Conscientiousness in PwMS.
OBJECTIVE: We hypothesized that Conscientiousness-associated WM tract disruption predicts new-onset depression over 5 years in PwMS and evaluated this by assessing the predictive power of mean Conscientiousness associated frontal-parietal network (CFPN) disruption in PwMS for clinically diagnosed depression over 5 years.
METHODS: This longitudinal retrospective analysis included 53 PwMS who were not previously diagnosed as depressed. All participants underwent structural MRI. Medical records were reviewed to evaluate diagnosis of depression for these patients over 5 years. WM tract damage between pairs of gray matter regions in the CFPN was measured using diffusion imaging. The relationship between CFPN disruption and depression was analyzed using logistic regression.
RESULTS: Participants with MS had a mean age of 46.0 years (SD = 11.2). 22.6% (n = 12) acquired a diagnosis of clinical depression over the 5-year period. Baseline disruption in the CFPN was a significant predictor (ROC AUC = 61.8%). of new-onset clinical depression, accounting for age, sex, lateral ventricular volume, disease modifying treatment, and lesion volume.
CONCLUSION: Baseline CFPN disruption is associated with progression to clinical depression over 5 years in PwMS. Development of new WM pathology within this network may be a risk factor for depression.

Entities:  

Keywords:  Conscientiousness; Depression; Diffusion imaging; Multiple sclerosis; White matter

Mesh:

Year:  2020        PMID: 32754832     DOI: 10.1007/s00415-020-10110-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  27 in total

1.  Personality traits in multiple sclerosis: association with mood and anxiety disorders.

Authors:  Jared M Bruce; Sharon G Lynch
Journal:  J Psychosom Res       Date:  2011-02-16       Impact factor: 3.006

Review 2.  An introduction to the five-factor model and its applications.

Authors:  R R McCrae; O P John
Journal:  J Pers       Date:  1992-06

3.  Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change.

Authors:  Ralph H B Benedict; Elizabeth Wahlig; Rohit Bakshi; Inna Fishman; Frederick Munschauer; Robert Zivadinov; Bianca Weinstock-Guttman
Journal:  J Neurol Sci       Date:  2005-01-26       Impact factor: 3.181

4.  Personality disorder in multiple sclerosis correlates with cognitive impairment.

Authors:  R H Benedict; R L Priore; C Miller; F Munschauer; L Jacobs
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2001       Impact factor: 2.198

5.  White matter tract network disruption explains reduced conscientiousness in multiple sclerosis.

Authors:  Tom A Fuchs; Michael G Dwyer; Amy Kuceyeski; Sanjeevani Choudhery; Keith Carolus; Xian Li; Matthew Mallory; Bianca Weinstock-Guttman; Dejan Jakimovski; Deepa Ramasamy; Robert Zivadinov; Ralph H B Benedict
Journal:  Hum Brain Mapp       Date:  2018-05-08       Impact factor: 5.038

Review 6.  Depression in multiple sclerosis: a review.

Authors:  R J Siegert; D A Abernethy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

Review 7.  Personality and depression: explanatory models and review of the evidence.

Authors:  Daniel N Klein; Roman Kotov; Sara J Bufferd
Journal:  Annu Rev Clin Psychol       Date:  2011       Impact factor: 18.561

8.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

9.  The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis.

Authors:  Rose Gelineau-Morel; Valentina Tomassini; Mark Jenkinson; Heidi Johansen-Berg; Paul M Matthews; Jacqueline Palace
Journal:  Hum Brain Mapp       Date:  2011-10-05       Impact factor: 5.038

10.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

View more
  3 in total

1.  Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate, or both?

Authors:  Dejan Jakimovski; Ralph H B Benedict; Bianca Weinstock-Guttman; Osman Ozel; Tom A Fuchs; Norah Lincoff; Niels Bergsland; Michael G Dwyer; Robert Zivadinov
Journal:  J Neurol       Date:  2021-02-15       Impact factor: 4.849

2.  Structural disconnectivity from paramagnetic rim lesions is related to disability in multiple sclerosis.

Authors:  Ceren Tozlu; Keith Jamison; Thanh Nguyen; Nicole Zinger; Ulrike Kaunzner; Sneha Pandya; Yi Wang; Susan Gauthier; Amy Kuceyeski
Journal:  Brain Behav       Date:  2021-09-08       Impact factor: 2.708

3.  Gray matter atrophy in relapsing-remitting multiple sclerosis is associated with white matter lesions in connecting fibers.

Authors:  Matthias Bussas; Sophia Grahl; Viola Pongratz; Achim Berthele; Christiane Gasperi; Till Andlauer; Christian Gaser; Jan S Kirschke; Benedikt Wiestler; Claus Zimmer; Bernhard Hemmer; Mark Mühlau
Journal:  Mult Scler       Date:  2021-09-30       Impact factor: 5.855

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.